Lymphedema Treatment Act
The Society, represented by Public Policy Advisor Chris Rorick, recently attended the Lymphedema Advocacy Group's 2018 Capitol Hill Awareness Day and Congressional awards ceremony on Capitol Hill. More than 70 national Lymphedema Advocacy Group leaders from around the country spent the day on Capitol Hill... culminating with an evening reception to present Congressional leadership awards to those Senate Congressional champions that have led the way in advancing lymphedema care and coverage legislation during this 115th Sessional of Congress.
Senators Cantwell (D-WA), Grassley (R-IA) and Schumer (D-NY) were all recognized for their legislative contributions to advance the "Lymphedema Treatment Act"... which is currently the most cosponsored piece of health care legislation in both the US Senate and House of Representatives.
The Lymphedema Treatment Act (H.R. 930 / S. 497) would amend Medicare statute to pay for compression garments, bandages and supplies to reduce lymphedema-related swelling and prevent recurrence. The bill has added 321 cosponsors in the House and 53 cosponsors in the Senate. With the overwhelming support from a majority of members of Congress, we are hopeful that the legislation will find a path to passage before the end of the calendar year.
As you well know, compression therapy is considered the gold standard for the treatment of lymphedema and the treatment and prevention of venous leg ulcers (VLUs), also known as stasis ulcers. The Society strongly supports the Lymphedema Treatment Act; this legislation reflects the vision and core tenets of the Society as a means to support cost-effective, evidence-based prevention and treatment of complex wound conditions such as VLUs and lymphedema.